Pollen-weeds Liquid
NDC Package 55714-4804-1
Package Information
Pollen-weeds (ginkgo biloba, hydrastis canadensis, taraxacum officinale, adrenalinum , aletris farinosa, alfalfa, allium cepa, antimonium tartaricum, arsenicum album, artemisia vulgaris, baptisia tinctoria, bellis perennis, berberis vulgaris, bryonia, calluna vulgaris, flos, chelidonium majus, chenopodium anthelminticum, dioscorea vilosa, euphrasia officinalis, fagus sylvatica, fraxinus americana, gelsemium sempervirens, histaminum hydrochloricum, kali bichromicum, kali iodatum, lachesis mutus, lilium tigrinum,) liquids is formulated for associated symptoms of Spring and early Summer pollens such as nasal catarrh, post-nasal drip, sneezing, glandular swellings and sore throat,. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4804.
Identification & Billing
Clinical Specifications
- CALLUNA VULGARIS FLOWERING TOP 20 [hp_X]/mL
- ULMUS RUBRA BARK 20 [hp_X]/mL
- FAGUS SYLVATICA NUT 20 [hp_X]/mL
- FRAXINUS AMERICANA BARK 20 [hp_X]/mL
- LILIUM LANCIFOLIUM WHOLE FLOWERING 20 [hp_X]/mL
- BELLIS PERENNIS 20 [hp_X]/mL
- ROSA DAMASCENA FLOWERING TOP 20 [hp_X]/mL
- TRIFOLIUM PRATENSE FLOWER 20 [hp_X]/mL
- SALIX NIGRA BARK 20 [hp_X]/mL
- PARTHENIUM HYSTEROPHORUS 20 [hp_X]/mL
- XEROPHYLLUM ASPHODELOIDES 20 [hp_X]/mL
- EPINEPHRINE 20 [hp_X]/mL
- ALFALFA 20 [hp_X]/mL
- ALETRIS FARINOSA ROOT 20 [hp_X]/mL
- ARTEMISIA VULGARIS ROOT 20 [hp_X]/mL
- DYSPHANIA AMBROSIOIDES 20 [hp_X]/mL
- LYCOPUS VIRGINICUS 20 [hp_X]/mL
- PHYTOLACCA AMERICANA ROOT 20 [hp_X]/mL
- POPULUS BALSAMIFERA LEAF BUD 20 [hp_X]/mL
- POPULUS TREMULOIDES LEAF 20 [hp_X]/mL
- PTELEA TRIFOLIATA BARK 11 [hp_X]/mL
- SAMBUCUS NIGRA FLOWERING TOP 11 [hp_X]/mL
- TRILLIUM ERECTUM ROOT 20 [hp_X]/mL
- ELYMUS REPENS ROOT 21 [hp_X]/mL
- URTICA URENS 20 [hp_X]/mL
- WYETHIA HELENIOIDES ROOT 20 [hp_X]/mL
- YUCCA FILAMENTOSA 20 [hp_X]/mL
- USTILAGO MAYDIS 20 [hp_X]/mL
- HISTAMINE DIHYDROCHLORIDE 20 [hp_X]/mL
- JUNIPERUS VIRGINIANA TWIG 21 [hp_X]/mL
- THYROID, UNSPECIFIED 20 [hp_X]/mL
- ONION 20 [hp_X]/mL
- ANTIMONY POTASSIUM TARTRATE 20 [hp_X]/mL
- ARSENIC TRIOXIDE 20 [hp_X]/mL
- BAPTISIA TINCTORIA ROOT 20 [hp_X]/mL
- BERBERIS VULGARIS ROOT BARK 20 [hp_X]/mL
- BRYONIA ALBA ROOT 20 [hp_X]/mL
- CHELIDONIUM MAJUS 20 [hp_X]/mL
- EUPHRASIA STRICTA 20 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT 20 [hp_X]/mL
- POTASSIUM DICHROMATE 20 [hp_X]/mL
- POTASSIUM IODIDE 11 [hp_X]/mL
- LACHESIS MUTA VENOM 20 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 20 [hp_X]/mL
- ANEMONE PULSATILLA 20 [hp_X]/mL
- SCHOENOCAULON OFFICINALE SEED 21 [hp_X]/mL
- DIOSCOREA VILLOSA TUBER 20 [hp_X]/mL
- GINKGO 20 [hp_X]/mL
- TARAXACUM OFFICINALE 20 [hp_X]/mL
- QUERCUS ROBUR NUT 20 [hp_X]/mL
- GOLDENSEAL 21 [hp_X]/mL
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Fungal Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Fungal Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Vegetable Proteins - [CS]
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4804 - Pollen-weeds
- 55714-4804-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4804 - Pollen-weeds
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4804-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Pollen-weeds, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains calluna vulgaris flowering top; ulmus rubra bark; fagus sylvatica nut; fraxinus americana bark; lilium lancifolium whole flowering; bellis perennis; rosa damascena flowering top; trifolium pratense flower; salix nigra bark; parthenium hysterophorus; xerophyllum asphodeloides; epinephrine; alfalfa; aletris farinosa root; artemisia vulgaris root; dysphania ambrosioides; lycopus virginicus; phytolacca americana root; populus balsamifera leaf bud; populus tremuloides leaf; ptelea trifoliata bark; sambucus nigra flowering top; trillium erectum root; elymus repens root; urtica urens; wyethia helenioides root; yucca filamentosa; ustilago maydis; histamine dihydrochloride; juniperus virginiana twig; thyroid, unspecified; onion; antimony potassium tartrate; arsenic trioxide; baptisia tinctoria root; berberis vulgaris root bark; bryonia alba root; chelidonium majus; euphrasia stricta; gelsemium sempervirens root; potassium dichromate; potassium iodide; lachesis muta venom; lycopodium clavatum spore; anemone pulsatilla; schoenocaulon officinale seed; dioscorea villosa tuber; ginkgo; taraxacum officinale; quercus robur nut; goldenseal as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on September 02, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714480401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.